Other Issues

Select an Issue

Browse Other Issues Content

Orange CHPA logo on dark blue background

Press Releases and Statements

CHPA Applauds House Introduction of DXM Abuse Prevention Act

CHPA is pleased to lend its strong support for the DXM Abuse Prevention Act of 2015 (H.R. 3250), introduced into the U.S. House of Representatives by U.S. Reps. Bill Johnson (R-OH) and Doris Matsui (D-CA).

Jul 28, 2015

Orange CHPA logo on dark blue background

Press Releases and Statements

CHPA Statement on FDA Drug Safety Communication on NSAIDs

The Consumer Healthcare Products Association today issued the following statement in response to the Food and Drug Administration’s Drug Safety Communication on non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs).

Jul 10, 2015

Clear gel capsules in a pile

Submission

Letter to Attorney General Regarding Tainted Dietary Supplements

May 19, 2015

lake and mountains

Press Releases and Statements

CHPA Comment on House Energy & Commerce Committee Microbeads Legislation

Consumer Healthcare Products Association President and CEO Scott Melville released the following statement today regarding this afternoon’s hearing on microbeads legislation.

May 1, 2015

Orange CHPA logo on dark blue background

Press Releases and Statements

CHPA Thanks Governor Bill Haslam for Signing Legislation

Apr 9, 2015

woman worker in protective clothing operating production of tablets in sterile environment

Submission

Comments to USP: Proposals for Developing Compendial Quality Standards for OTC Drugs

Letter to Principal Scientific Liaison, U.S. Pharmacopeia, regarding Proposals for Developing Compendial Quality Standards for OTC Drugs.

Apr 3, 2015

Man wrapped in a blanket blowing his nose.

Research Reports

A Summary of the Key Differences Between the FDA’s Drug and Dietary Supplement GMPs

In general, the Part 111 GMP requirements, although similar, are less stringent and tend to be more flexible than the Part 211 GMP requirements.

Mar 4, 2015

dandelion, capsules, and brown bottle

Articles

New York Attorney General Questions Certain Herbal Dietary Supplements – But Scientists, Experts Say the AG Used the Wrong Test

Scientific experts familiar with herbal products and their testing methods maintain that the DNA barcode test is not an appropriate method to determine what is in an herbal dietary supplement.

Feb 23, 2015

blue green capsules on white background

Submission

Comments to FDA: Proprietary Name Reservation for Drug Products

In principle, CHPA supports an early approval program for proposed proprietary drug names. However, should FDA decide to implement a program, we expect that FDA would publish a draft Guidance for Industry and we would provide further comment based on the criteria.

Oct 27, 2014

Orange CHPA logo on dark blue background

Submission

Comments to USP: <909> Uniformity of Dose from Oral Suspensions in Multi-Unit Containers

Letter to Mr. Brown regarding U.S. Pharmacopeia draft publication, "General Chapter <909> Uniformity of Dose from Oral Suspensions in Multi-Unit Containers."

Sep 30, 2014

Filter Results